Pitolisant is an investigational first-in-class highly selective histamine receptor agonist/inverse agonist. The drug offers a novel option to treat the condition of both EDS and cataplexy for narcolepsy.
According to the recent studies performed in the field of narcolepsy therapeutics, combination therapy has emerged as a more effective solution for sleepiness in comparison to the efficiency exhibited by a single drug. In February 2019, Harmony Biosciences received the US Food and Drug Administration’s acceptance to prioritize the review for New Drug Application for Pitolisant intended to treat the excessive daytime sleepiness among adult patients suffering with narcolepsy with cataplexy. Pitolisant is an investigational first-in-class highly selective histamine receptor agonist/inverse agonist. The drug offers a novel option to treat the condition of both EDS and cataplexy for narcolepsy. The company aims to consider histamine as a potential lead molecule and prove its efficiency in improving the sleep-wake state instability. The booming studies on narcolepsy combination drugs are likely to be under the clinical trial phases within a few years. Recently, the new drug, Wakix, was approved as treatment for excessive daytime sleepiness associated with narcolepsy.
The major driving factors are rising prevalence of sleep related neurological disorders, emerging local pharmaceutical and biopharmaceutical companies, and increasing awareness regarding neurological disorders are expected to boost the market growth over the years. However, side effects and risks associated with the narcolepsy medications and delayed diagnosis and misdiagnosis of the disease are likely to pose a negative impact on the market growth.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Severity: Warning
Message: count(): Parameter must be an array or an object that implements Countable
Filename: amp/news_details_amp.php
Line Number: 252
Backtrace:
File: /home/smartmarketnews/public_html/application/views/amp/news_details_amp.php
Line: 252
Function: _error_handler
File: /home/smartmarketnews/public_html/application/controllers/Amp_controller.php
Line: 41
Function: view
File: /home/smartmarketnews/public_html/index.php
Line: 315
Function: require_once
Smarter Decisions with Smart News
Smart Market News is committed to getting its readers the latest updates and insights on industries that help in making “smarter” business decisions. With insights and inputs from corporate decision makers, we bring you the stories of adopting innovative solutions and strategies that have been changing the world. Our editorial insights on products, solutions, companies, and adoption of best practices not only help in understanding the markets better, but also prove to be a complete package for your information needs.
media@smartmarketnews.com | sales@smartmarketnews.com
Contact Us